Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 24
Filter
Add more filters










Publication year range
1.
Bull Cancer ; 79(9): 883-91, 1992.
Article in French | MEDLINE | ID: mdl-1486224

ABSTRACT

Forty patients with intermediate stage (T2 > 3 cm-T3, N0-N1) operable breast cancer received neoadjuvant chemotherapy by MCF (mitoxantrone, cyclophosphamide, 5-fluorouracil). Four cycles were administered at 3-week intervals. The obvious hematological toxicity (64% of grade III for the leucocytes and up to 34% of grade IV for the granulocytes) was rapidly reversible and did not hinder completion of the treatment. Ten patients showed a complete remission and a tumor volume regression of more than 50% was observed in 12 other patients. Tumor shrinkage allowed breast-saving surgery in 50% of the cases. A complete sterilisation of the surgical specimen was found in only two of the 40 patients and a few persisting neoplastic cells were found in ten other cases. A positive response at the level of the axillary lymph nodes was also obtained in more than 50% of the cases. In 25 of the 36 cases examined, the primary chemotherapy induced cellular lesions (fibrosis, necrosis) at the tumor level. A feasibility study was undertaken in order to determine quantitatively several biochemical parameters (steroid hormone receptors, cathepsin D, c-erbB-2 oncoprotein) in very small tumor samples obtained by Tru-Cut before any treatment and in surgical specimens. In the future, these micromethods will be used systematically with the aim of estimating the value of these potential prognostic factors for therapeutic follow-up of the patients.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Breast Neoplasms/therapy , Adult , Aged , Breast Neoplasms/drug therapy , Breast Neoplasms/pathology , Breast Neoplasms/surgery , Combined Modality Therapy , Cyclophosphamide/therapeutic use , Female , Fluorouracil/therapeutic use , France , Humans , Middle Aged , Mitoxantrone/therapeutic use , Neoplasm Staging , Remission Induction
5.
Ann Biol Clin (Paris) ; 43(3): 215-20, 1985.
Article in French | MEDLINE | ID: mdl-2411171

ABSTRACT

The authors analysed the alkaline phosphatases present in the serum of a patient with cholangiocarcinoma. The electrophoretic analysis on cellulose acetate revealed two bands of AP activity in positions alpha 1 and alpha 2. The more anodic of the isoenzymes of AP presented most of the features of the high molecular weight isoenzyme found in human bile, except that it was non-competitively inhibited by L-homoarginine. This feature, which distinguishes this isoenzyme form the biliary isoenzyme of AP, indicates the existence of another type of high molecular weight isoenzyme present in malignant hepatic diseases.


Subject(s)
Adenoma, Bile Duct/enzymology , Alkaline Phosphatase/blood , Bile Duct Neoplasms/enzymology , Hepatic Duct, Common , Isoenzymes/blood , Aged , Alkaline Phosphatase/isolation & purification , Chromatography, Gel , Chromatography, Ion Exchange/methods , Electrophoresis, Cellulose Acetate , Homoarginine/pharmacology , Humans , Isoenzymes/isolation & purification , Liver/enzymology , Male , Molecular Weight
6.
Contraception ; 29(4): 305-18, 1984 Apr.
Article in English | MEDLINE | ID: mdl-6430638

ABSTRACT

For various metabolic and clinical reasons, it has been strongly advocated to reduce the dose of both the estrogen and progestogen components of oral contraceptives (OCs). In this study, we compared after 6 months of treatment, the action on various hormonal parameters of a standard-dose combined OC containing ethinylestradiol (EE) 0.050 mg and levonorgestrel (LNg) 0.250 mg and a low-dose triphasic combination containing a 59% reduced amount of the same steroids. Hormonal measurements in the last 3 days of OC intake indicated that basal levels of FSH and LH were less inhibited by the low-dose preparation, while PRL levels were unchanged. However, gonadal function was effectively inhibited by both high and low dose OCs, as demonstrated by equally low levels of E2, E1, P and 17-P. Consequently, no residual gonadal function could be anticipated from the observed low steroid concentrations. These results corroborated other studies (reviewed in this paper) in which serial hormonal measurements also revealed a complete lack of follicular maturation during low-dose triphasic OC treatment. Moreover, inhibition of circulating levels of A, DHEA, DHEAS, free T and DHT was similarly obtained with both preparations. Collectively, these data indicate that ovarian function is as effectively inhibited by a low-dose triphasic preparation as by a higher, standard-dose OC containing the same steroids.


PIP: For various metabolic and clinical reasons, it has been strongly recommended that the dose of both the estrogen and progestogen components of oral contraceptives (OCs) be reduced. In this study, the authors compared, after 6 months of treatment, the action on various hormonal parameters of astandard-dose combined OC containing ethinyl estradiol (EE) 0.050 mg and levonorgestrel (LNg) 0.250 mg and a low-dose triphasic combination containing a 59% reduced amount of the same steroids. Hormonal measurements in the last 3 days of OC intake indicated that basal levels of FSH and LH were less inhibited by the low-dose preparation, while prolactin (PRL) levels were unchanged. However, gonadal function was effectively inhibited by both high and low dose OCs, as demonstrated by equally low levels of E2, E1, P, and 17-P. Thus, no residual gonadal function could be anticipated from the observed low steroid concentrations. These results corrborated other studies (also reviewed in this paper) in which serial hormonal measurements also revealed a complete lack of follicular maturation during low-dose triphasic OC treatment. Moreover, inhibition ofcirculating levels of A, DHEA, DHEAS, free T and DHT was similarly obtained with both preparations. Collectively, these data indicate that ovarian function is as effectively inhibited by a low-dose triphasic preparation as by a higher, standard-dose OC containing the same steroids.


Subject(s)
Contraceptives, Oral, Combined/pharmacology , Contraceptives, Oral/pharmacology , Ethinyl Estradiol/pharmacology , Norgestrel/pharmacology , Ovary/physiology , Adult , Androgens/blood , Dose-Response Relationship, Drug , Estrogens/blood , Female , Gonadotropins, Pituitary/blood , Humans , Levonorgestrel , Ovarian Follicle/growth & development , Ovulation/drug effects , Plasma/analysis , Progesterone/blood
7.
Eur J Biochem ; 137(3): 603-8, 1983 Dec 15.
Article in English | MEDLINE | ID: mdl-6662113

ABSTRACT

In rat liver, the perinatal development of various monooxygenase activities follows different patterns, depending upon the reaction studied. The ontogeny of the 6 beta-, 7 alpha- and 16 alpha-testosterone hydroxylase activities differs very significantly. Aldrin epoxidase and steroid-metabolizing monooxygenases are expressed in primary fetal rat liver cells in culture after treatment in vitro with dexamethasone. Testosterone is not metabolized by the control cells and is hydroxylated on the 6 beta and 16 alpha positions following the addition of corticoids to the culture medium. The dose and time curves vary according to the hydroxylated position of the steroid. Aldrin epoxidase activity is nearly undetectable in the control cells, but is present and is inducible by phenobarbital following treatment with the corticoid. Phenobarbital induces aldrin epoxidase in the absence of dexamethasone in the culture medium, providing that the cells are pretreated with the corticoid for 48 h. The use of antibodies against the main cytochrome P-450 species purified from adult and phenobarbital-treated rats confirms that a similar cytochrome P-450 can be induced in fetal cells in culture. The perinatal regulation of biological events, such as the expression of the monooxygenases, can be reproduced in fetal rat liver cells in culture; such a model constitutes a unique tool for studying the biochemical mechanisms which control these phenomena.


Subject(s)
Aryl Hydrocarbon Hydroxylases , Cytochrome P-450 Enzyme System/metabolism , Dexamethasone/pharmacology , Liver/enzymology , Mixed Function Oxygenases/metabolism , Steroid Hydroxylases/metabolism , Animals , Animals, Newborn/metabolism , Cells, Cultured , Fetus/enzymology , Liver/embryology , Rats , Rats, Inbred Strains
8.
Contraception ; 27(6): 577-90, 1983 Jun.
Article in English | MEDLINE | ID: mdl-6225622

ABSTRACT

The changes in plasma hormone levels were evaluated in matched healthy female volunteers investigated before and after 6 months' use of three new oral contraceptives (OCs): TrigynonR (n = 13), a triphasic OC containing low doses of ethinylestradiol (EE) + levonorgestrel (LNg); MarvelonR (n = 14), a monophasic OC containing low doses of EE + desogestrel (DOG, a new progestogen derived from LNg); and OvidolR (n = 10), a sequential OC containing higher doses (50 micrograms) of EE + DOG. Serum levels of FSH, LH, estradiol and progesterone were decreased in all cases to levels incompatible with ovulation. Prolactin concentrations were unchanged. Sex hormone binding globulin (SHBG) and Transcortin (CBG) levels were significantly increased by all three OCs (Ovidol greater than Marvelon greater than Trigynon); free testosterone levels decreased significantly while free cortisol concentrations remained unchanged. Collectively, these data indicate that (a) all three OCs are effective ovulation inhibitors, (b) Ovidol and Marvelon have greater estrogenic effects than Trigynon, (c) LNg is more effective than DOG in reducing the EE-induced increase in SHBG levels, and (d) free testosterone levels are equally well suppressed by all three Ocs.


Subject(s)
Contraceptives, Oral, Combined/pharmacology , Contraceptives, Oral/pharmacology , Ethinyl Estradiol/pharmacology , Gonadal Steroid Hormones/blood , Gonadotropins, Pituitary/blood , Norgestrel/pharmacology , Norpregnenes/pharmacology , Serum Globulins/analysis , Adult , Desogestrel , Estradiol/blood , Female , Follicle Stimulating Hormone/blood , Humans , Levonorgestrel , Luteinizing Hormone/blood , Progesterone/blood , Prolactin/blood , Random Allocation , Sex Hormone-Binding Globulin/analysis , Transcortin/analysis
9.
Ann Dermatol Venereol ; 110(3): 213-9, 1983.
Article in French | MEDLINE | ID: mdl-6614735

ABSTRACT

For a 29 months period, from June 1979 to November 1981. 11 cases of Kaposi Sarcoma (3 women and 8 men) have been diagnosed in Port-au-Prince. Two more cases (men) were seen in haitian refugees in Miami (C. D. C. report). Only one case of K. S. had been diagnosed in Haïti previously in 1972. The mean age was 37. Involvement of lymph nodes and viscera were frequent and the patients died within 24 months (the mean survival time after diagnosis was 5 months). This apparent outbreak probably has no relation with that one in U. S. homosexuals which appeared simultaneously. Drugs and homosexuality have no importance in haitian cases. K. S. in U. S. homosexuals and in heterosexual haitians has a bad prognosis as in Africans: they all differ from the classical european and north american forms by the age of onset, the frequent visceral involvement and the early death. The review of histological data and different etiological factors lead to think that it is the same disease everywhere in spite of those marked differences.


Subject(s)
Sarcoma, Kaposi/epidemiology , Adult , Female , Haiti , Humans , Male , Middle Aged , Sarcoma, Kaposi/pathology
11.
Clin Chim Acta ; 112(1): 21-32, 1981 Apr 27.
Article in English | MEDLINE | ID: mdl-7237822

ABSTRACT

Plasma steroid concentrations measured in the post-menopausal women with breast cancer showed a close correlation between the various androgens. The post-menopausal women exhibited a correlation between estrogen receptors (ER) and "arterial" 17 alpha-hydroxyprogesterone levels in the breast. ER levels expressed as a function of plasma (arterial) steroid (P/17 P) molar concentration ratio were distributed within a hyperbola, suggesting the existence of a control mechanism for breast cell ER levels.


Subject(s)
Androgens/blood , Breast Neoplasms/metabolism , Estrogens/blood , Progesterone/blood , Receptors, Estrogen/metabolism , Aged , Arteries , Cytosol/metabolism , Female , Humans , Menopause , Middle Aged , Veins
13.
J Genet Hum ; 28(3): 207-12, 1980 Sep.
Article in French | MEDLINE | ID: mdl-6780658

ABSTRACT

Among hormones which can be determined in the amniotic fluid in the mid-pregnancy period, testosterone and F.S.H. allow the best discrimination between sexes (Figure 1). Moreover, F.S.H. is clearly increasing during the 2d trimester of pregnancy in case of a female fetus. This is a quick and reliable method which uses a small quantity of amniotic fluid. Combined with chromosomal analysis, it increases the accuracy of the sex diagnosis and indicates a repeat amniocentesis if there is a discrepancy between karyotype and hormonal determinations.


Subject(s)
Amniotic Fluid/metabolism , Follicle Stimulating Hormone/metabolism , Sex Determination Analysis , Testosterone/metabolism , Amniocentesis , Female , Humans , Male , Pregnancy , Pregnancy Trimester, Second , Prenatal Diagnosis
15.
Clin Endocrinol (Oxf) ; 9(4): 303-11, 1978 Oct.
Article in English | MEDLINE | ID: mdl-363307

ABSTRACT

Basal concentrations of FSH, LH, testosterone, delta4 androstenedione and dihydrotestosterone, together with FSH and LH responses to single injections of LHRH were determined in eighty-four patients with oligospermia and in twenty-seven normal men. LHRH responses were heterogeneous and indicate that various disorders might cause this syndrome. In six cases there appeared to be an isolated deficiency in spermatogenesis, as indicated by an increased FSH response, whilst the LH response was normal as were the concentrations of the testicular hormones. In twenty cases a concomitant disorder of Leydig cell function and spermatogenesis is suggested as indicated by increased FSH and LH responses and decreased concentrations of testosterone and delta4 androstenedione (six) or concentrations at the lower limit of normal (fourteen). Furthermore, in five cases a hypothalamic and/or pituitary disturbance may be accepted on the basis of normal or decreased basal concentrations decreased and responses to LHRH with decreased concentrations of testosterone and delta4 androstenedione. Finally, in thirty-seven cases, oligospermia was not associated with any modification basal gonadotrophin concentrations or response to LHRH when compared with normal subjects.


Subject(s)
Androstenedione/blood , Dihydrotestosterone/blood , Follicle Stimulating Hormone/blood , Luteinizing Hormone/blood , Oligospermia/blood , Testosterone/blood , Adult , Gonadotropin-Releasing Hormone , Humans , Male , Oligospermia/physiopathology
16.
Ann Biol Clin (Paris) ; 36(4): 389-91, 1978.
Article in French | MEDLINE | ID: mdl-367230

ABSTRACT

The development of enzymo-immunological technics and the synthesis of efficacious immuno-adsorbants has given rise to several immuno-enzymometric methods of which one, ELISA (enzyme-linked immunosorbent assay) has proved particularly practical and sensitive for the estimation of antibodies.


Subject(s)
Antibodies/analysis , Enzyme-Linked Immunosorbent Assay/methods , Immunoenzyme Techniques/methods , Antibodies, Bacterial/analysis , Antibodies, Viral/analysis , Eukaryota , Helminths , Polystyrenes
19.
Biochimie ; 57(5): 521-8, 1975.
Article in English | MEDLINE | ID: mdl-810179

ABSTRACT

The relative quantities of PGE2 and PGF2alpha biosynthesized are strictly dependent on the concentration of the precursor, arachidonate, on the nature and on the quantity of sulfhydrylated cofactor present. The sigmoid aspect of the curve of PGF2alpha biosynthesis as a function of arachidonate concentration is directly dependent on the GSH concentration. Treatment of the microsomes by low concentrations of HgCl (5 muM) modifies the kinetics of PGE2 and PGF2alpha biosynthesis. Similarly, the presence of L-8027, a competitive inhibitor, alters qualitatively and quantitatively the production of PGE2 and PGF2alpha as a function of arachidonate concentration.


Subject(s)
Mixed Function Oxygenases/metabolism , Prostaglandin-Endoperoxide Synthases/metabolism , Seminal Vesicles/enzymology , Animals , Arachidonic Acids/metabolism , Binding, Competitive , Cattle , Cyclooxygenase Inhibitors , Deoxycholic Acid/pharmacology , Dithiothreitol/pharmacology , Epinephrine/pharmacology , Glutathione/pharmacology , In Vitro Techniques , Indoles/pharmacology , Kinetics , Male , Mercury/pharmacology , Prostaglandins E/biosynthesis , Prostaglandins F/biosynthesis , Pyridines/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...